Maize-soy flour

DIETARY_SUPPLEMENT2 trials

Sponsors

Tampere University

Conditions

Developmental DelayMalnutritionStunting

Phase 3

Controlled Trial to Test the Efficacy of Lipid-based Nutrient Supplements to Prevent Severe Stunting Among Infants

CompletedNCT00524446

Tampere UniversityDevelopmental Delay, Malnutrition, Stunting

Start: 2008-01-31End: 2014-01-31Target: 840Updated: 2014-05-21

Prevention of Linear Growth Failure in Infants and Young Children With Lipid-based Nutrient Supplements (iLiNS-DOSE)

CompletedNCT00945698

Tampere UniversityMalnutrition

Start: 2009-11-30End: 2014-08-31Target: 1920Updated: 2015-05-27

Related Papers

Does anthropometric status at 6 months predict the over-dispersion of malaria infections in children aged 6-18 months? A prospective cohort study.

2019-04-222 citations

The association of malaria morbidity with linear growth, hemoglobin, iron status, and development in young Malawian children: a prospective cohort study.

2018-12-289 citations

Maternal and Child Supplementation with Lipid-Based Nutrient Supplements, but Not Child Supplementation Alone, Decreases Self-Reported Household Food Insecurity in Some Settings.

2017-10-049 citations

Absolute Quantitation of Human Milk Oligosaccharides Reveals Phenotypic Variations during Lactation.

2016-10-19129 citations

Provision of Lipid-Based Nutrient Supplements from Age 6 to 18 Months Does Not Affect Infant Development Scores in a Randomized Trial in Malawi.

2016-10-0120 citations

Lipid-Based Nutrient Supplements Increase Energy and Macronutrient Intakes from Complementary Food among Malawian Infants.

2016-01-0621 citations

Provision of 10-40 g/d Lipid-Based Nutrient Supplements from 6 to 18 Months of Age Does Not Prevent Linear Growth Faltering in Malawi.

2015-06-1072 citations

Malawian Mothers Consider Lipid-Based Nutrient Supplements Acceptable for Children throughout a 1-Year Intervention, but Deviation from User Recommendations Is Common.

2015-05-2018 citations

Lipid-based nutrient supplements do not affect the risk of malaria or respiratory morbidity in 6- to 18-month-old Malawian children in a randomized controlled trial.

2014-09-1715 citations